Ad is loading...
CEUFX
Price
$55.68
Change
-$0.54 (-0.96%)
Updated
Nov 15 closing price
RERAX
Price
$53.01
Change
-$0.52 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

CEUFX vs RERAX

Header iconCEUFX vs RERAX Comparison
Open Charts CEUFX vs RERAXBanner chart's image
American Funds Europacific Growth 529F1
Price$55.68
Change-$0.54 (-0.96%)
VolumeN/A
CapitalizationN/A
American Funds Europacific Growth R1
Price$53.01
Change-$0.52 (-0.97%)
VolumeN/A
CapitalizationN/A
CEUFX vs RERAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CEUFX vs. RERAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CEUFX is a Buy and RERAX is a Buy.

FUNDAMENTALS
Fundamentals
CEUFX (129B) and RERAX (129B) have equal amount of cash in the bank . CEUFX pays higher dividends than RERAX: CEUFX (1.68) vs RERAX (0.91). CEUFX was incepted earlier than RERAX: CEUFX (22 years) vs RERAX (22 years). CEUFX (34.00) and RERAX (34.00) have comparable annual turnover. CEUFX (250) and RERAX (250) have matching initial minimum investment requirements. CEUFX annual gain was more profitable for investors over the last year : 8.78 vs. RERAX (7.63). CEUFX return over 5 years is better than : 10.41 vs. RERAX (3.85).
CEUFXRERAXCEUFX / RERAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years22 years-
Gain YTD3.9383.052129%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets129B129B100%
Annual Yield % from dividends1.680.91184%
Returns for 1 year8.787.63115%
Returns for 3 years-16.47-19.4585%
Returns for 5 years10.413.85270%
Returns for 10 years32.2515.89203%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APP291.096.60
+2.32%
Applovin Corp
BBDC9.950.06
+0.61%
Barings BDC
SIF3.60N/A
N/A
SIFCO Industries
CNS100.47-0.25
-0.25%
Cohen & Steers
FATE2.02-0.06
-2.88%
Fate Therapeutics